microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer

ReseaRch PaPeR

www.landesbioscience.com epigenetics 1

epigenetics 9:1, 1–8; January 2014; © 2014 Landes Bioscience

ReseaRch PaPeR

*Correspondence to: Wai-Yee Chan; Email: [email protected]: 06/13/13; Revised: 07/14/13; Accepted: 07/18/13http://dx.doi.org/10.4161/epi.25799

Introduction

Epigenetic mechanisms, including methylation, histone modification, nucleosome positioning and non-coding RNAs, are essential for normal development and maintenance of gene expression patterns in mammals. Abnormalities of these epi-genetic processes have been regarded as closely related to dis-ease development, including human cancer.1 Currently, three DNA methyltransferases, namely, DNMT1, DNMT3A, and DNMT3B, have been identified to be responsible for DNA methylation in mammals. All of them facilitate the transfer of the methyl group from S-adenosyl-methionine (SAM) to the C in CpG site. DNMT1 is responsible for the maintenance of meth-ylation, and it has a 30- to 40-fold preference for hemimethylated DNA, while DNMT3A and DNMT3B play a role in de novo methylation, being responsible for establishing the methylation pattern necessary during embryonic development.2

Testicular germ cell tumors (TGCTs) are the most frequent solid tumor of Caucasian adolescents and young adult males and are a diverse group of neoplasms that can also be present in extragonadal sites.3 Histologically, TGCTs are divided into seminomas, which resemble primordial germ cells (PGCs) and non-seminomas, which are either undifferentiated (embryonal

carcinoma) or differentiated (embryonic [teratoma] or extra-embryonic [yolk sac choriocarcinoma]).4 In the previous genome-wide DNA methylation profiling study on TGCT conducted in our lab, larger numbers of differentially methylated regions (DMRs) were identified in NT2 cells and clinical TGCT sam-ples, compared with normal human testicular cells (HT) and normal testis tissues.5 Intriguingly, DNMT1 was upregulated in embryonal carcinoma,6 DNMT3B was overexpressed in non-seminomas,7,8 and significant upregulation of DNMT3A2 but not DNMT3A was observed in TGCT (seminomas and non-seminomas).9 Although aberrant DNA methylation and overex-pressed DNMTs were also observed in other cancer types,1 the causes of the change of methylation pattern and the overexpres-sion of DNMTs have not been fully elucidated.

The DNMT3A2 isoform of DNMT3A gene was first reported by Chen et al.10 in 2002. The DNMT3A genomic locus contains two genes, DNMT3A1 and DNMT3A2. Transcription of the DNMT3A2 isoform is initiated from a different promoter in the sixth intron of the DNMT3A gene; thus, the DNMT3A2 protein (approximately 82 kDa) lacks the N-terminal 223 (human) or 219 (mouse) amino acid residues of the full-length DNMT3A1 (termed as the long isoform, approximately 120 kDa). Recombinant DNMT3A2 protein displayed similar

It was previously demonstrated that miR-199a was downregulated in testicular germ cell tumor (TGcT), probably due to hypermethylation of its promoter. Further study found that re-expression of miR-199a in testicular cancer cells (NT2) led to suppression of cell growth, cancer migration, invasion and metastasis. More detailed analyses showed that these properties of miR-199a could be assigned to miR-199a-5p, one of its two derivatives. The biological role of the other derivative, miR-199a-3p in TGcT, remains largely uncharacterized. In this report, we identified DNa (cytosine-5)-methyltransferase 3a (DNMT3a), the de novo methyltransferase, as a direct target of miR-199a-3p using a 3'-UTR reporter assay. Transient expression of miR-199a-3p in NT2 cells led to decrease, while knocking down of miR-199a-3p in a normal human testicular cell line (hT) led to elevation, of DNMT3a2 (DNMT3a gene isoform 2) mRNa and protein levels. In clinical samples, DNMT3a2 was significantly overexpressed in malignant testicular tumor, and the expression of DNMT3a2 was inversely correlated with the expression of miR-199a-3p. however, DNMT3a did not affect miR-199a expression in NT2 cells. Further characterization of miR-199a-3p revealed that it negatively regulated DNa methylation, partly through targeting DNMT3a. Overexpression of miR-199a-3p restored the expression of aPc and MGMT tumor-suppressor genes in NT2 cells by affecting DNa methylation of their promoter regions. Our studies demonstrated the deregulation of miR-199a-3p expression in TGcT may provide novel mechanistic insights into TGcT carcinogenesis and suggested a potentially therapeutic use of synthetic miR-199a-3p oligonucleotides as effective hypomethylating compounds in the treatment of TGcT.

microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer

Bi-Feng chen1, shen Gu1, Yick-Keung suen1, Lu Li1, and Wai-Yee chan1,*

1Key Laboratory for Regenerative Medicine; Ministry of education; school of Biomedical sciences; Faculty of Medicine; The chinese University of hong Kong; hong Kong, PR china

Keywords: miR-199a-3p, DNMT3A, DNA methylation, testicular cancer

©20

13 L

ande

s B

iosc

ienc

e. D

o no

t dis

tribu

te.

2 epigenetics Volume 9 Issue 1

cytosine methyltransferase activity as DNMT3A in vitro.10 A high-throughput gene-specific DNA methylation analysis of HEK 293T cells stably transfected with two DNMT3A isoforms separately, revealed that DNMT3A1 and DNMT3A2 shared 93% DNA methylation target sites.11 Suetake et al.12 found that the N-terminal sequence from residues 1–211 of full-length DNMT3A1 isoform was able to bind to DNA, but could not distinguish methylated and unmethylated CpG, and contribute to higher DNA-binding and DNA-methylation activities for DNMT3A1 compared with DNMT3A2.

miRNAs, typically around 21 nucleotides in length, are a well-studied class of short ncRNAs in mammalian cells. The precise biological effects of miRNAs are far from being under-stood, even though miRNAs are known to bind to the 3'UTR of their target gene mRNAs and induce their translational repres-sion, deadenylation or degradation.13 Recent studies indicated that some specific miRNAs could play an important role in the control of global methylation pattern through targeting the DNA methylation machinery. These include the miR-29 family,14 miR-152,15 mir-126,16 and miR-450a.17 A newcomer is hsa-miR-199a, a miRNA transcribed as antisense of DYNAMIN 3 (chromo-some 1q24.3), shown to be downregulated in TGCT.5 pre-miR-199a is encoded by two loci in the human genome, miR-199a-1 in chromosome 19 and miR-199a-2 in chromosome 1. Both loci encode the same mature hsa-miR-199a. Previous studies showed that the promoters of both miR-199a-1 and miR-199a-2 were

hypermethylated resulting in silencing of the expression of miR-199a in TGCTs (refs. 5 and 18 and Shen Gu et al., unpublished). Treatment of NT2 cells with 5-aza upregulated the expression of hsa-mir-199a by 42-fold.18 Further studies found that re-expres-sion of miR-199a in testicular cancer cells (NT2) led to suppres-sion of cell growth, cancer migration, invasion and metastasis.18 More detailed analyses showed that these properties of miR-199a could be assigned to miR-199a-5p, one of its two derivatives. The biological role of the other derivative, miR-199a-3p in TGCT, remains largely uncharacterized. Interestingly, as predicted by several in silico methods for target gene prediction, includ-ing PicTar,19 TargetScan,20 miRNA.org,21 and DIANA LAB,22 DNMT3A was identified as one of the high-scoring candidate targets of miR-199a-3p. Thus, it is possible that miR-199a-3p can regulate global DNA methylation pattern through direct target-ing of DNMT3A, leading to the speculation that downregula-tion of miR-199a-3p may be a potential cause of overexpression of DNMT3A. Since hsa-miR-199a is downregulated in TGCT due to its hypermethylated promoter, it is also questionable whether DNMT3A could negatively regulate the expression of hsa-miR-199a.

Results

DNMT3A2 is significantly upregulated in NT2 cells com-pared with HT cells. The expression of DNMT3A (isoform 1 and 2) in HT cells and NT2 cells was compared by RT-qPCR. DNMT3A1 showed 1.5-fold upregulation in NT2 cells, whereas DNMT3A2 showed 44-fold upregulation (Fig. 1A and B). Results of western blot analysis corroborated with this observa-tion (Fig. 1C).

DNMT3A is the direct target of miR-199a-3p. DNMT3A was predicted to be one of the miR-199a-3p targets with high probability by several in silico methods. DNMT3A1 and DNMT3A2 share the same 3'-UTR. Therefore, both mRNAs are putative targets of miR-199a-3p (Fig. 2A). To validate the miRNA-target interactions, the fragment of DNMT3A-3'-UTR containing the putative miR-199a-3p recognition sequence was cloned into the luciferase reporter vector pmirGLO. The recom-binant plasmid was co-transfected with miR-199a-3p mimics or negative control RNA, or empty pmirGLO with miR-199a-3p mimics, into NT2 cells. As shown in Figure 2B, When co-trans-fected with miR-199a-3p mimics, the relative luciferase activities of pmirGLO-DNMT3A-3UTR luciferase reporter in NT2 cells were significantly suppressed by almost 50% compared with the transfection with negative control and empty pmirGLO vector.

miR-199a-3p regulates endogenous DNMT3A expression, especially DNMT3A2 expression. To test the hypothesis that miR-199a-3p downregulates DNMT3A expression in NT2 cells, mRNA levels (as measured by RT-qPCR) and protein levels (as measured by western blot analysis) of DNMT3A1/2 isoforms were measured 48 h after transient transfection of miR-199a-3p mimics into NT2 cells. The results showed that miR-199a-3p expression caused a significant decrease of DNMT3A1 and DNMT3A2 expression at both mRNA and protein levels in com-parison with the negative control in NT2 cells. The reduction of

Figure 1. expression of DNMT3a1/2 in hT and NT2 cell lines. (A) DN-MT3a1 isoform expression and (B) DNMT3a2 isoform expression in hT and NT2 cells were assessed by RT-PcR. (C) DNMT3a1/2 protein levels in hT and NT2 cells.

Figure 2. miR-199a-3p directly targets DNMT3a. (A) The putative human DNMT3a 3'-UTR fragment containing miR-199a-3p binding sequence (837bp ~843bp) was inserted into the luciferase report vector pmirGLO downstream. (B) Dual luciferase assay of NT2 cells co-transfected with the luciferase constructs containing the DNMT3a 3'-UTR as well as miR-199a-3p mimics or scrambled oligonucleotides as the negative control.

©20

13 L

ande

s B

iosc

ienc

e. D

o no

t dis

tribu

te.


DNMT3A2 expression was more significant (p = 0.0104) (Fig. 3A–C). Knocking down of miR-199a-3p expression in HT cells using an anti-miRNA inhibitor specific for miR-199a-3p resulted in significant upregulation of DNMT3A1/2 mRNA and protein expression, especially DNMT3A2 (p = 0.0017) (Fig. 3D–F).

miR-199a-3p and DNMT3A2 are reciprocally regulated in clinical samples. The expression levels of miR-199a-3p and DNMT3A (1/2) in 25 clinical samples was tested. DNMT3A2 was significantly upregulated in tumor tissues (either embryo-nal carcinoma or seminoma) compared with normal tissues (Fig. 4B), but no significant difference of DNM3A1 expression was observed between tumor tissues (neither in embryonal carcinoma nor in seminoma) and normal tissues (Fig. 4A). Significantly downregulated expression of miR-199a-3p was observed in tumor tissues (either in embryonal carcinoma or in seminoma) (Fig. 4C). In addition, a statistically significant inverse correlation was observed between DNMT3A2 mRNA and miR-199a-3p in clinical samples (n = 25, r = -0.591, p = 0.002. Pearson’s cor-relation; Fig. 4D). These data showed the reciprocal regulation of the tumor suppressor miR-199a-3p and its target DNMT3A2 in human TGCTs and suggested that downregulation of miR-199a-3p may play a causal role in aberrant DNA methylation leading to TGCT development.

DNMT3A does not negatively regulate pre-miR-199a expression via promoter methylation in NT2 cells. Since hsa-miR-199a-3p is silenced in NT2 cells, and a significant inverse correlation was observed between DNMT3A2 mRNA expression and miR-99a-3p mRNA expression, the possibility remains that DNMT3A expression could downregulate pre-miR-199a expres-sion via promoter hypermethylation. To test this hypothesis, DNMT3A expression was inhibited by transfecting siDNMT3A (small interfering RNA specifically targeting DNMT3A) in NT2 cells. Similar to the observation made with miR-199a-3p overex-pression, siDNMT3A significantly downregulated DNMT3A1 and DNMT3A2 expression at both mRNA and protein levels, and the reduction of DNMT3A2 expression was more significant (Fig. 5A–C) (two-tailed Student’s t test, p = 0.0188 for Fig. 5A, p = 0.0008 for Fig. 5B, triplicate samples). After 48h of trans-fection, the expression of two mature miRNAs of pre-miR-199a, miR-199a-3p and 5p, were significantly upregulated (Student’s test, p = 0.0165 for Fig. 5D and p = 0.0021 for Fig. 5E, triplicate samples) (Fig. 5D and E). Methylation-specific PCR (MSP) was used to examine the promoter methylation changes of pre-miR-199a. Five sets of MSP primers were designed, of which two sets of primers focus on two CpG rich regions of miR-199a-1, and three sets of primers focus on three CpG rich regions of miR-199a-2. Each set of primers contains two pairs of primers to amplify either methylated or unmethylated alleles. miR-199a-1 is localized in chromosome 19, with a size of 71 bp (+1 to +71) in human genome (10 928 102–10 928 172). The two regions selected for MSP analysis, based on their CpG content and being at the 5' end of the gene,23 are (-472 to +97) for M1/U1 and (-472 to -11) for M2/U2. miR-199a-2 is localized in chromosome 1, with a size of 110 bp (+1 to +110) in human genome (172 113 675–172 113 784). The three regions selected for MSP analysis are (-21 to +396) for M1/U1, (+65 to +374) for M2/U2 and (-21 to +100)

for M3/U3. These three regions were previously identified to be in the potential promoter of miR-199a-2.18 MSP results showed that the promoter methylation levels of pre-miR-199a in the two loci were not significantly changed after transfection with siD-NMT3A (Fig. 5F). Taken together, these results indicated that DNMT3A expression did not negatively regulate pre-miR-199a expression via promoter methylation in NT2 cells.

Figure 3. miR-199a-3p regulates DNMT3a expression. (A) DNMT3a1 mRNa and (B) DNMT3a2 mRNa expression after the transfection with miR-199a-3p mimics or negative control (Nc) in NT2 cells. (C) DNMT3a1/2 protein expression of NT2 cells transfected with miR-199a-3p mimics or Nc. (D) DNMT3a1 mRNa (E) DNMT3a2 mRNa expression after the trans-fection with an anti-miRNa inhibitor specific for miR-199a-3p or negative control (Nc) in hT cells. (F) DNMT3a1/2 proteins expression of hT cells transfected with an anti-miRNa inhibitor specific for miR-199a-3p or Nc.

Figure 4. miR-199a-3p expression and DNMT3a2 mRNa levels inversely correlate in human TGcT tissues. (A) DNM3a1 mRNa expression (B) DN-MT3a2 mRNa expression (C) miR-199a-3p expression in TGcT tissues compared with Normal testis tissues. (D) miR-199a-3p and DNMT3a2 mRNa expression levels inversely correlated in 25 clinical samples. sta-tistical analysis to evaluate correlation was performed using Pearson’s correlation analysis (r = −0.591, p = 0.002).

©20

13 L

ande

s B

iosc

ienc

e. D

o no

t dis

tribu

te.


Changes of miR-199a-3p affect the expression of APC and MGMT tumor-suppressor genes (TSGs), as well as the DNA methylation patterns of their promoter regions in NT2 cells. DNA hypermethylation contributes to the silencing of TSGs involved in testicular tumorigenesis.24 Downregulation of miR-199a-3p allowed for increased DNMT3A2 expression, which could cause increased methylation. It was reasoned that the increased DNA methylation through this mechanism would

hypermethylate some TSGs and facilitate the develop-ment of TGCT. Several TSGs have been identified as being frequently hypermethylated in TGCT, includ-ing PRSS21, RASSF1A, MGMT, SCGB3A1, HIC1, HOXA9, APC, and RUNX1.25,26 To assess whether miR-199a-3p could affect the mRNA expression of these 8 TSGs, miR-199a-3p was overexpressed in NT2 cells, and RT-qPCR was used to quantitate the expres-sion level of the TSGs. Figure 6A showed that 5 of 8 tested TSGs (MGMT, SCGB3A1, HIC1, HOXA9 and APC) were significantly upregulated in the miR-199a-3p mimics group compared with negative con-trol group. Next, the expression of miR-199a-3p was suppressed with an anti-miRNA inhibitor specific for miR-199a-3p in HT cells, RT-qPCR results revealed that three of the five TSGs were significantly down-regulated in the miR-199a-3p inhibitor group, com-pared with the control group (Fig. 6B). These results suggested that in TGCT, APC, MGMT, and SCGB3A1 were indirectly affected by miR-199a-3p, probably through the action of DNMT3A. In fact, the expres-sion of APC, MGMT and SCGB3A1 was upregu-lated in the siDNMT3A group in which DNMT3A was knocked down, when compared with the NC group (Fig. 6C). It indicated that APC, MGMT and SCGB3A1 were affected by DNMT3A. To examine whether miR-199a-3p regulated the expression of these three TSGs through affecting their promoter meth-ylation, the promoter methylation patterns of APC, MGMT, and SCGB3A1 genes in NT2 and HT cells were assessed using bisulfite sequencing PCR (BSP) method. Consistent with previous observation, all three TSGs were hypermethylated in NT2 cells com-pared with HT cells (APC, 38.1% vs. 3.75%; MGMT, 40.7% vs. 12.7%; SCGB3A1, 42.2% vs. 17.8% (Fig. S1). Furthermore, after transfection of miR-199a-3p mimics into NT2 cells, promoters methylation of APC and MGMT were significantly decreased in the miR-199a-3p mimics group compared with control (APC, 24.4% vs. 40.6%; MGMT, 14.3% vs. 39.2%), while the promoter methylation of SCGB3A1 was not sig-nificantly changed (Fig. 6D).

miR-199a-3p does not significantly affect the expression of other DNMTs and TETs in NT2 cells. Recent studies have shown that the TET family pro-teins can catalyze 5-methylcytosine (5mC) oxida-tion and generate 5-hydroxymethylcytosine (5hmC), which is essential for DNA demethylation.27 Thus,

there is a possibility that miR-199a-3p affects promoter meth-ylation of some TSGs via the other DNMTs and TETs instead of DNMT3A alone. To rule out the involvement of the other DNMTs (DNMT1/3B) and TETs (TET1/2/3), the effects of miR-199a-3p on these epigenetic enzymes were investigated. RT-qPCR results indicated that enhanced miR-199a-3p expres-sion did not significantly affect the expression of DNMT1, DNMT3B and the three members of the TET family (Fig. 7).

Figure 5. DNMT3a does not negatively regulate miR-199a expression via promoter methylation in NT2 cells. DNM3a1 mRNa expression (A), DNMT3a2 mRNa expres-sion (B) and their protein levels (C) after transfection of siDNMT3a into NT2 cells. (D) MiR-199a-3p mRNa expression and (E) miR-199a-5p mRNa expression after transfection of siDNMT3a into NT2 cells. (F) pre-miR-199a promoter methylation on chromosome 1 and chromosome 19 in NT2 cells after siDNMT3a transfection.

Figure 6. enforced miR-199a-3p expression decreases methylation of some gene promoters in NT2 cell lines. (A) PRSS21, RASSF1A, MGMT, SCGB3A1, HIC1, HOXA9, APC, and RUNX1 mRNa expression levels in NT2 cells after transfection of miR-199a-3p mimics. (B) APC, HIC1, HOXA9, MGMT and SCGB3A1 mRNa expression levels in hT cells after transfection of miR-199a-3p inhibitor. (C) APC, HIC1, HOXA9, MGMT and SCGB3A1 mRNa expression levels in NT2 cells after transfection of siDNMT3a. (D) The promoter methylation pattern of APC, MGME and SCGB3A1 in NT2 cells after transfection of miR-199a-3p mimics.

©20

13 L

ande

s B

iosc

ienc

e. D

o no

t dis

tribu

te.


Discussion

Significant changes of global DNA methylation have been observed in cultured cancer cells and primary human tumor tis-sues. Aberrant hypermethylated CpG islands have been reported in almost every tumor type, including testicular germ cell tumors.5 As discussed earlier, aberrant DNA methylation and overexpressed DNMTs were observed in TGCT or its subtypes. However, the underlying mechanisms remained not unclear. The current studies focused on the relationship between miR-199a-3p and DNMT3A in seminoma and embryonal carcinoma, a sub-type of non-seminomas. Results obtained are relevant to these two subtypes of TGCT.

Ishii and colleagues9 recently examined the expression of DNMT3A mRNA and protein in TGCTs, RT-PCR analysis revealed that DNMT3A and DNMT3A2 were significantly overexpressed in seminomas as well as non-seminomas, while western blot results revealed that DNMT3A2 protein level but not DNMT3A1 protein level was several times higher than control levels in both seminomatous and non-seminomatous TGCTs. The upregulation of DNMT3A2 in TGCT could par-tially contribute to the aberrant DNA methylation of TGCT and account for the hypermethylation of CpG islands observed in the promoters of many genes. In mammals, global de novo methyla-tion occurs in the primordial germ cells at the early stage during germ cells development and plays a critical role in the establish-ment of genomic imprinting.28 As a de novo DNA methyltrans-ferase, DNMT3A2 was predominantly observed at this stage together with the co-expressed DNMT3L. Dnmt3a2 recruits Dnmt3l to chromatin and induces regional DNA methylation in male germ cells.29,30 Moreover, Dnmt3a2 transcripts were at its highest level in type A spermatogonia, and decreased dramati-cally in type B spermatogonia in mouse.31 These evidences sug-gested that a tightly regulated expression pattern of DNMT3A2 is critical for normal germ cell development, which, when altered, will lead to pathological changes, such as embryonal carcinoma tumorigenesis.

In the current study, we confirmed that DNMT3A1 isoform showed slight upregulation in NT2 cell lines but no upregulation in clinical non-seminomas and seminomas, while DNMT3A2 did show significant upregulation in NT2 cell lines as well as in non-seminomas and seminomas tissues. The dual luciferase reporter assay results showed that miR-199a-3p directly targets DNMT3A, and miR-199a-3p expression inversely correlated with DNMT3A2 expression in clinical samples (r = −0.591, p = 0.002). Furthermore, miR-199a-3p expression significantly downregulated the DNMT3A2 expression in NT2 cells, while suppressed miR-199a-3p expression allowed significant upregu-lation of DNMT3A2 in HT cells. These observations suggest an epigenetic regulatory role for miR-199a-3p in TGCT. The observation of the difference in the knockdown efficiency of miR-199a-3p on the DNMT3A isoforms could be the result of the difference in the tertiary structure of the mRNA of the iso-forms, which affects the binding efficiency of the miRNA to the DNMT3A mRNAs, even though they have the same 3'UTR. Since miR-199a-3p normally functions as an upstream inhibitor

of DNMT3A2 expression, downregulation of miR-199a-3p will allow for upregulation of DNMT3A2. This provides the mecha-nism of the overexpressed DNMT3A2 in TGCT and suggests a tumor suppressor role for miR-199a-3p via regulating methyla-tion in TGCT. To this end, we characterized the role of miR-199a-3p in the restoration of hypermethylated TSGs in NT2 cell lines. Specifically, three of 8 selected TSGs, namely, APC, MGMT, and SCGB3A1, were identified as indirectly affected by miR-199a-3p, probably through the action of DNMT3A. These three TSGs were shown previously to exhibit hypermethylation in TGCT.24,32,33 Consistent with previous study, our data showed that all three genes were hypermethylated in NT2 cells compared with HT cells. Further, overexpressed miR-199a-3p in NT2 cells reduced the promoter methylation of APC and MGMT genes. However, no significant change of SCGB3A1 promoter meth-ylation was observed, which may suggest that miR-199a-3p regulates SCGB3A1 via methylation at a different region of the gene.34 Moreover, since miR-199a-3p expression did not sig-nificantly affect the expression of DNMT1, DNMT3B and the three members of the TET family, it confirmed that the change of DNA methylation level caused by miR-199a-3p was credited to targeting of DNMT3A.

In conclusion, our data demonstrated that miR-199a-3p directly targeted DNMT3A, and that miR-199a-3p significantly regulated the expression of DNMT3A2 isoform in NT2 cells. Further correlation study revealed a statistically significant inverse correlation between miR-199a-3p mRNA level and DNMT3A2 mRNA level in clinical samples. In addition, restoration of APC and MGMT, induced by miR-199a-3p overexpression in NT2 cells, coincided with significant DNA hypomethylation of their promoter regions, suggesting the hypomethylation function of miR-199a-3p, which implicated a potential therapeutic use of synthetic miR-199a-3p oligonucleotides as effective hypometh-ylating compounds in the treatment of TGCT. However, since DNMT3A expression did not significantly change pre-miR-199a expression, the mechanism of pre-miR-199a hypermethylation in TGCT needs further investigation.

Methods

Primary TGCT specimens. Genomic RNA (11 cases, 6 embryonal carcinoma and 5 seminoma) samples obtained from

Figure 7. miR-199a-3p does not significantly affect the expression of other DNMTs and TeTs in NT2 cells. DNMT1, DNMT3B, TeT1, TeT2 and TeT3 mRNa expression levels after transfection of miR-199a-3p mimics into NT2 cells.

©20

13 L

ande

s B

iosc

ienc

e. D

o no

t dis

tribu

te.


TGCT patients were purchased from Oncomatrix. Normal tes-ticular RNA (14 cases) were purchased from Zyagen. Each RNA samples was isolated from a single individual.

Cell culture and transfection. Ntera 2 (NT2), an established pluripotent human testicular embryonal carcinoma cell lines,35 as well as normal human testis cell line Hs 1.Tes (CRL-7002™) were purchased from ATCC (Manassas, VA, USA) supple-mented with 10% FBS and incubated in a 37 °C humidified incubator supplied with 5% CO2. Synthetic double-stranded miR-199a-3p mimics, miR-199a-3p inhibitor or scramble oli-gonucleotides used as negative control (GenePharma) at a final concentration of 20 nM were introduced into NT2 cells or HT cells by Lipofectamine 2000 kit (Invitrogen) according to the

manufacturer’s instructions. Transfected cells were harvested at 24, 48, or 72 h.

Inhibition of DNMT3A expression. The small interfering RNA (siRNA) specifically targeting DNMT3A (siDNMT3A) was obtained commercially (GenePharma). The synthetic siD-NMT3A or negative control siRNA at a final concentration of 20 nM were introduced into NT2 cells by using Lipofectamine 2000 kit (Invitrogen) as previously described by cell culture and transfection methods. Transfected cells were harvested at 24 or 48 h.

Construction of luciferase reporter vector. The fragment (+562 bp ~+1202 bp) of DNMT3A 3'-untranslated region (3'-UTR, total of 1303 bp) containing an intact miR-199a-3p

Table 1. Primers for clone PcR, real-time RT-PcR, methylation specific PcR (MsP) and bisulfite sequencing PcR (BsP) assays

Assay Gene namePrimer sequence (5'-3')

Forward Reverse

clone 3'-UTR DNMT3a TaGGaGcTca aGcaGGGGac GGaa GcGcTcGaGT TGGcTaaaGT GaGaaac

Real-time RT-PcR

DNMT3a1 acccaGcGca GaaGcaG aTaGaTcccG GTGTTGaGcc

DNMT3a2 TacTTccaGa GcTTcaGGGc aTTccTTcTc acaacccGc

PRss21 TGGGGGTaca TcaaaGaGGa cTTGaGGaaG aGGTGGTTGc

RassF1 TcGaGcaGTa cTTcaccGc GaaaGGTcaG GTGTcTccca

MGMT GGGTcTGcac GaaaTaaaGc cTccGGaccT ccGaGaac

scGB3a1 cTcTGcGTGG cccTGTc cTTcaGcGGG TTGaGGGT

hIc1 TGcGacaaGa GcTacaaGGa GTGaacTTcT TcccGcaGaT

hOXa9 aaTGcTGaGa aTGaGaGcGG GTaTaGGGGca ccGcTTTTT

aPc GGaGacaGaa TGGaGGTGcT TcTTcaGTGc cTcaacTTGc

RUNX1 cacTGccTTT aacccTcaGc caaTGGaTcc caGGTaTTGG

GaPDh TGcaccacca acTGcTTaGc GGcaTGGacT GTGGTcaTGaG

stem loop primer for miR-199a-3p GTTGGcTcTG GTGcaGGGTc cGaGGTaTTc GcaccaGaGc caactaacca

miR-199a-3p GGTGcaGGGT ccGaGGTaT GGcGGacaGT aGTcTGcacaT

stem loop primer for miR-199a-5p GTTGGcTcTG GTGcaGGGTc cGaGGTaTTc GcaccaGaGc caacgaacag

miR-199a-5p GGTGcaGGGT ccGaGGTaT cGGcccaGTG TTcaGacTac

U6 GcTTcGGcaG cacaTaTacT aaaaT cGcTTcacGa aTTTGcGTGT caT

Methylation specific PcR (MsP)

miR-199a-chr1-M1 GTTTTTaGcG GTTTaTGGc aacGaTTcTa acGaTcTcTcc

miR-199a-chr1-U1 TTTGTTTTTa GTGGTTTaTG GT aacaaTTcTa acaaTcTcTc caac

miR-199a-chr1-M2 aGTTTGaaTa TTGGGGcGac acGacacaac GcaTaccc

miR-199a-chr1-U2 GGTaGTTTGa aTaTTGGGGT GaT ccaacaacac aacacaTacc c

miR-199a-chr1-M3 GTTTTTaGcG GTTTaTGGc cTaaaaaTcc TacTccGTcG

miR-199a-chr1-U3 TTTGTTTTTa GTGGTTTaTG GT TcTaaaaaTc cTacTccaTc acc

miR-199a-chr19-M1 TcGGTcGTaa TGaGaaaTaG Tc TaaacGacTc GTcGaaaca

miR-199a-chr19-U1 GTTGGTTGTa aTGaGaaaTa GTT aTaaacaacT caTcaaaaca

miR-199a-chr19-M2 TcGGTcGTaa TGaGaaaTaG Tc TcGcaTaaaa aaTTcGaaaa

miR-199a-chr19-U2 GTTGGTTGTa aTGaGaaaTa GTT cTcacaTaaa aaaTTcaaaa a

Bisulfite sequencing PcR (BsP)

aPcGaGGaaGGTG aaGTaTTTaG

TTGTTTTTacaaccTca cTcaccTacc aaac

MGMT GGTaTTaGGa GGGGaGaGaT T TaTaccTTaa TTTaccaaaT aaccc

scGB3a1 aGGGaTTaGG GaGTTaGGaa TTG acccTcTaaa aacaaacaaa ccc

©20

13 L

ande

s B

iosc

ienc

e. D

o no

t dis

tribu

te.


References1. Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin

2010; 60:376-92; PMID:20959400; http://dx.doi.org/10.3322/caac.20085

2. Lan J, Hua S, He XN, Zhang Y. DNA methyltrans-ferases and methyl-binding proteins of mammals. Acta Biochim Biophys Sin (Shanghai) 2010; 42:243-52; PMID:20383462; http://dx.doi.org/10.1093/abbs/gmq015

3. Gilbert D, Rapley E, Shipley J. Testicular germ cell tumours: predisposition genes and the male germ cell niche. Nat Rev Cancer 2011; 11:278-88; PMID:21412254; http://dx.doi.org/10.1038/nrc3021

4. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005; 5:210-22; PMID:15738984; http://dx.doi.org/10.1038/nrc1568

5. Cheung HH, Lee TL, Davis AJ, Taft DH, Rennert OM, Chan WY. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer. Br J Cancer 2010; 102:419-27; PMID:20051947; http://dx.doi.org/10.1038/sj.bjc.6605505

6. Omisanjo OA, Biermann K, Hartmann S, Heukamp LC, Sonnack V, Hild A, Brehm R, Bergmann M, Weidner W, Steger K. DNMT1 and HDAC1 gene expression in impaired spermatogenesis and testicu-lar cancer. Histochem Cell Biol 2007; 127:175-81; PMID:16960727; http://dx.doi.org/10.1007/s00418-006-0234-x

7. Almstrup K, Hoei-Hansen CE, Nielsen JE, Wirkner U, Ansorge W, Skakkebaek NE, Rajpert-De Meyts E, Leffers H. Genome-wide gene expression pro-filing of testicular carcinoma in situ progression into overt tumours. Br J Cancer 2005; 92:1934-41; PMID:15856041; http://dx.doi.org/10.1038/sj.bjc.6602560

8. Korkola JE, Houldsworth J, Dobrzynski D, Olshen AB, Reuter VE, Bosl GJ, Chaganti RS. Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene 2005; 24:5101-7; PMID:15870693; http://dx.doi.org/10.1038/sj.onc.1208694

9. Ishii T, Kohu K, Yamada S, Ishidoya S, Kanto S, Fuji H, Moriya T, Satake M, Arai Y. Up-regulation of DNA-methyltransferase 3A expression is associated with hypomethylation of intron 25 in human testicular germ cell tumors. Tohoku J Exp Med 2007; 212:177-90; PMID:17548962; http://dx.doi.org/10.1620/tjem.212.177

10. Chen T, Ueda Y, Xie S, Li E. A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J Biol Chem 2002; 277:38746-54; PMID:12138111; http://dx.doi.org/10.1074/jbc.M205312200

recognition sequence were amplified by PCR from genomic DNA and inserted into the Firefly/Renilla dual reporter vector pmirGLO (Promega) at the 3'-end of the firefly luciferase gene (luc2). The primers for construction of pmirGLO-DNMT3A-3'-UTR vector was shown in Table 1.

Reverse-Transcription reaction (RT) and quantitative real-time PCR (qPCR). The harvested cells were placed in TRIzol® Reagent (Invitrogen), and total RNAs were extracted accord-ing to the TRIzol manufacturer’s instructions. Total RNA (1 μg) was primed by random hexamers and converted into cDNA using SuperScript III (Invitrogen). The SYBR green-based real-time PCR was performed in an Applied Biosystems 7900HT Fast Real-Time PCR System (Applied Biosystems), and GAPDH was used as an endogenous control to normal-ize the amount of total mRNA in each sample. The expression of mature miR-199a-3p and miR-199a-5p were measured using the well-established stem-loop RT-qPCR method as previously described,36 and the level of miRNAs expression were normal-ized by U6 RNA. Real-time PCR was performed with a stan-dard SYBR-Green PCR kit protocol on ABI 7900HT Fast Real Time PCR system (Applied Biosystems). The primer sequences were summarized in Table 1.

Luciferase reporter assay. An amount of 3 × 104 NT2 cells were plated in each well of a 24-well plate the day before transfection. NT2 cells were co-transfected with pmirGLO-DNMT3A-3'UTR construct and miR-199a-3p mimics or a neg-ative control, or co-transfected with empty pmirGLO plasmid and miR-199a-3p mimics by Lipofectamine 2000 (Invitrogen) as previously described by cell culture and transfection methods. Four wells for each group in a single independent experiment. A luciferase activity assay was performed 48 h after transfection with the dual luciferase reporter assay system (Promega). The relative luciferase activity was normalized with Renilla luciferase activity.

Western blot analysis. Total cell lysate was prepared in a 1x sodium dodecyl sulfate buffer. Proteins in the same amount were separated by sodium dodecyl sulfate–PAGE and transferred onto polyvinylidene fluoride membranes. After incubation with antibodies specific for either DNMT3A (monoclonal antibody 64B1446) (Abeam) or GAPDH (Abeam), the blots were incu-bated with goat anti-mouse (Santa Cruz Biotechnology) and

visualized with enhanced chemiluminescence. The monoclonal antibody 64B1446 detects both isoforms of DNMT3A1 and DNMT3A2, as the two polypeptides have a common carboxyl-terminal catalytic domain.10

Methylation specific PCR (MSP) and bisulfite sequencing PCR (BSP). DNA was extracted using Invitrogen™ genomic DNA extraction kits. The bisulfite conversion of gDNA (400 ng) was conducted with EZ DNA Methylation-Gold™ Kit (Zymo Research Corporation). MSP and BSP were performed as previously described.37,38 The bisulfite-treated DNA (80–100 ng) was amplified with the methylation-specific primers or the unmethylated-specific primers, and the amplified products were analyzed on agarose gel. To perform the BSP, the bisulfite-treated DNA (80–100 ng) was amplified using primers that are specific for the modified DNA but do not contain any CpG sites in their sequence. The resulting PCR product was cloned into TOPO® TA Cloning® Kit (Invitrogen) and 8–10 positive clones were directly sequenced. The primer sequences were summarized in Table 1.

Statistical analysis. The expressions of miR-199a-3p, DNMT3A1 and DNMT3A2 in primary TGCT specimens and normal testis tissues were compared by the Mann-Whitney Test. The relationship of miR-199a-3p and DNMT3A2 mRNA expression levels was analyzed by Pearson’s correlation. The dif-ferences for luciferase assay and RT-qPCR data were determined by two-tailed Student’s t test, data are expressed as means and standard deviations (SD) from at least three independent experi-ments. All p values were two-sided and were obtained with the SPSS 16.0 software package (SPSS). A p value < 0.05 was consid-ered statistically significant.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

This research was supported by the start-up fund provided by the Chinese University of Hong Kong.

Supplemental Material

Supplemental material may be found here: www.landesbioscience.com/journals/epigenetics/article/25799

©20

13 L

ande

s B

iosc

ienc

e. D

o no

t dis

tribu

te.


11. Choi SH, Heo K, Byun HM, An W, Lu W, Yang AS. Identification of preferential target sites for human DNA methyltransferases. Nucleic Acids Res 2011; 39:104-18; PMID:20841325; http://dx.doi.org/10.1093/nar/gkq774

12. Suetake I, Mishima Y, Kimura H, Lee YH, Goto Y, Takeshima H, Ikegami T, Tajima S. Characterization of DNA-binding activity in the N-terminal domain of the DNA methyltransferase Dnmt3a. Biochem J 2011; 437:141-8; PMID:21510846; http://dx.doi.org/10.1042/BJ20110241

13. Osada H, Takahashi T. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 2007; 28:2-12; PMID:17028302; http://dx.doi.org/10.1093/carcin/bgl185

14. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, et al. MicroRNA-29 family reverts aber-rant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007; 104:15805-10; PMID:17890317; http://dx.doi.org/10.1073/pnas.0707628104

15. Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010; 52:60-70; PMID:20578129; http://dx.doi.org/10.1002/hep.23660

16. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S, Yin H, Lu Q. MicroRNA-126 regulates DNA methyla-tion in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 2011; 63:1376-86; PMID:21538319; http://dx.doi.org/10.1002/art.30196

17. Weng Z, Wang D, Zhao W, Song M, You F, Yang L, Chen L. microRNA-450a targets DNA methyltrans-ferase 3a in hepatocellular carcinoma. Exp Ther Med 2011; 2:951-5; PMID:22977604

18. Cheung HH, Davis AJ, Lee TL, Pang AL, Nagrani S, Rennert OM, Chan WY. Methylation of an intronic region regulates miR-199a in testicular tumor malig-nancy. Oncogene 2011; 30:3404-15; PMID:21383689; http://dx.doi.org/10.1038/onc.2011.60

19. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA tar-gets. Cell 2003; 115:787-98; PMID:14697198; http://dx.doi.org/10.1016/S0092-8674(03)01018-3

20. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37:495-500; PMID:15806104; http://dx.doi.org/10.1038/ng1536

21. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008; 36(Database issue):D149-53; PMID:18158296; http://dx.doi.org/10.1093/nar/gkm995

22. Maragkakis M, Vergoulis T, Alexiou P, Reczko M, Plomaritou K, Gousis M, Kourtis K, Koziris N, Dalamagas T, Hatzigeorgiou AG. DIANA-microT Web server upgrade supports Fly and Worm miRNA target prediction and bibliographic miRNA to dis-ease association. Nucleic Acids Res 2011; 39(Web Server issue):W145-8; PMID:21551220; http://dx.doi.org/10.1093/nar/gkr294

23. Antequera F. Structure, function and evolution of CpG island promoters. Cell Mol Life Sci 2003; 60:1647-58; PMID:14504655; http://dx.doi.org/10.1007/s00018-003-3088-6

24. Koul S, Houldsworth J, Mansukhani MM, Donadio A, McKiernan JM, Reuter VE, Bosl GJ, Chaganti RS, Murty VV. Characteristic promoter hypermeth-ylation signatures in male germ cell tumors. Mol Cancer 2002; 1:8; PMID:12495446; http://dx.doi.org/10.1186/1476-4598-1-8

25. Lind GE, Skotheim RI, Lothe RA. The epig-enome of testicular germ cell tumors. APMIS 2007; 115:1147-60; PMID:18042148; http://dx.doi.org/10.1111/j.1600-0463.2007.apm_660.xml.x

26. Okamoto K, Kawakami T. Epigenetic profile of tes-ticular germ cell tumours. Int J Androl 2007; 30:385-92, discussion 392; PMID:17521367; http://dx.doi.org/10.1111/j.1365-2605.2007.00754.x

27. Tan L, Shi YG. Tet family proteins and 5-hydroxymeth-ylcytosine in development and disease. Development 2012; 139:1895-902; PMID:22569552; http://dx.doi.org/10.1242/dev.070771

28. Smallwood SA, Kelsey G. De novo DNA methylation: a germ cell perspective. Trends Genet 2012; 28:33-42; PMID:22019337; http://dx.doi.org/10.1016/j.tig.2011.09.004

29. Nimura K, Ishida C, Koriyama H, Hata K, Yamanaka S, Li E, Ura K, Kaneda Y. Dnmt3a2 targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation. Genes Cells 2006; 11:1225-37; PMID:16999741; http://dx.doi.org/10.1111/j.1365-2443.2006.01012.x

30. Sakai Y, Suetake I, Shinozaki F, Yamashina S, Tajima S. Co-expression of de novo DNA methyltransferases Dnmt3a2 and Dnmt3L in gonocytes of mouse embryos. Gene Expr Patterns 2004; 5:231-7; PMID:15567719; http://dx.doi.org/10.1016/j.modgep.2004.07.011

31. La Salle S, Trasler JM. Dynamic expression of DNMT3a and DNMT3b isoforms during male germ cell development in the mouse. Dev Biol 2006; 296:71-82; PMID:16725135; http://dx.doi.org/10.1016/j.ydbio.2006.04.436

32. Smith-Sørensen B, Lind GE, Skotheim RI, Fosså SD, Fodstad O, Stenwig AE, Jakobsen KS, Lothe RA. Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer. Oncogene 2002; 21:8878-84; PMID:12483540; http://dx.doi.org/10.1038/sj.onc.1205978

33. Lind GE, Skotheim RI, Fraga MF, Abeler VM, Esteller M, Lothe RA. Novel epigenetically deregu-lated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1). J Pathol 2006; 210:441-9; PMID:17029216; http://dx.doi.org/10.1002/path.2064

34. Ramachandran K, Gopisetty G, Gordian E, Navarro L, Hader C, Reis IM, Schulz WA, Singal R. Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target. Cancer Res 2009; 69:1527-35; PMID:19190346; http://dx.doi.org/10.1158/0008-5472.CAN-08-3609

35. Pleasure SJ, Lee VM. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J Neurosci Res 1993; 35:585-602; PMID:8411264; http://dx.doi.org/10.1002/jnr.490350603

36. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179; PMID:16314309; http://dx.doi.org/10.1093/nar/gni178

37. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996; 93:9821-6; PMID:8790415; http://dx.doi.org/10.1073/pnas.93.18.9821

38. Li Y, Tollefsbol TO. DNA methylation detection: bisul-fite genomic sequencing analysis. Methods Mol Biol 2011; 791:11-21; PMID:21913068; http://dx.doi.org/10.1007/978-1-61779-316-5_2

©20

13 L

ande

s B

iosc

ienc

e. D

o no

t dis

tribu

te.

microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer

Documents

Transcript of microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer